Supply Chain
Contrary to federal law, CMS accepted $15.1 million in gross drug costs for prescriptions written by excluded providers from 2006 to 2008 under the Medicare Part D program, according to a recent report from the Office of Inspector General.
The U.S. Department of Justice announced late last week that GE Healthcare has paid more than $30 million to the government to settle False Claims Act allegations.
As drug shortages become more frequent and severe, providers are feeling the financial impact of the higher-priced alternatives and the personnel hours required to deal with the escalating problem.
Even though the Centers for Medicare & Medicaid Services has taken steps to curtail fraud and abuse from Medicare suppliers of durable medical equipment, prosthetics, orthotics and supplies (DMEPOS), it needs to do more says a recently released report from the Office of Inspector General.
Healthcare real estate will continue to be a strong investment category in 2012 concludes an analysis by Jones Lang LaSalle, a financial and professional services firm specializing in real estate.
Pfizer received a flurry of attention toward the end of November as its blockbuster statin Lipitor came to the end of its patent protection.
Pharmaceutical companies outsourced $36.6 billion in global research and development expenses to contract drug developers in 2011, up 6.6 percent from 2009, according to healthcare research firm Kalorama Information.
The proportion of Americans reporting problems affording prescription drugs remained level between 2007 and 2010, with more than one in eight going without a prescribed drug in 2010, according to a national study released today by the Center for Studying Health System Change. Despite the flat numbers, the news isn't necessarily good.
Fujifilm Holdings Corporation announced Wednesday that it has entered into a definitive agreement to acquire ultrasound technology firm SonoSite, Inc. for approximately $995 million.
Cardinal Health, a Dublin, Ohio-based, Fortune 19, healthcare services company has been ranked in the number one spot in Gartner's third annual Healthcare Supply Chain Top 25, replacing med-surg supplier Owens & Minor, which dropped to fifth place.